Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

about

MALT lymphoma: epidemiology, clinical diagnosis and treatment

P2860

Q58570743-377F48D5-A806-4F1E-B5E2-BA1C902DF414

P2860

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

Item

http://www.wikidata.org/entity/Q55717193

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@en

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@nl

type

Item

label

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@en

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@nl

prefLabel

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@en

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

@nl

P1476

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment

@en

P2093

Julio C Chavez

http://www.w3.org/2001/XMLSchema#string

Lubomir Sokol

http://www.w3.org/2001/XMLSchema#string

Samir Dalia

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

Helicobacter pylori infection and gastric lymphoma

Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study

Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy

P304

1073274818778256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1073274818778256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

L M Juárez Salcedo

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29779412

http://www.w3.org/2001/XMLSchema#string

P932

6028178

http://www.w3.org/2001/XMLSchema#string

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

about

P2860

P2860

Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932